Concurrently, it reduces markers of oxidative stress and promotes the activity of anti-inflammatory mediators
[20] Treatment of megaloblastic anemia with concurrent vitamin B 12 deficiency using B 12 vitamers (including cyanocobalamin), creates the possibility of hypokalemia due to increased erythropoiesis (red blood cell production) and consequent cellular uptake of potassium upon anemia resolution
A 2025 pilot study showed intravenous BPC-157 was tolerated without side effects but did not measure efficacy in tendon healing
By promoting tissue regeneration, reducing inflammation, and stimulating the growth of new blood vessels, BPC-157 helps restore function and alleviate pain
CAUTION:Not for use if pregnant or nursing
Common formulations include: BPC-157: 10 mg per vial in typical KLOW formulations TB-500: 10 mg per vial in typical KLOW formulations GHK-Cu: 50 mg per vial in typical KLOW formulations (highest proportion) KPV: 10 mg per vial in typical KLOW formulations Total blend: 80 mg combined peptide content Individual component research dosing: BPC-157 studies: 10 mcg/kg most common in rat models (range: 1-1000 mcg/kg) TB-500 studies: 1-10 mg/kg typical range in rodent research GHK-Cu studies: 0.01-100 nanomolar in cell culture
